Medicare Enrolled

Dr. Atul Kumar, M.D., MBA

Medical Oncology · Pensacola, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
5151 N 9TH AVE, Pensacola, FL 32504
8504167000
In practice since 2006 (19 years)
NPI: 1316049257 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kumar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kumar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kumar

Dr. Atul Kumar is a medical oncology specialist in Pensacola, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kumar performed 574 Medicare services across 494 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kumar received a total of $32,726 from 18 pharmaceutical and/or device companies across 48 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kumar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 574 Medicare services $32,726 industry payments

Medicare Practice Summary

Medicare Utilization ↗
574
Medicare services
Bottom 39% in FL for medical oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
494
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~30 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity 178 $60 $198
Initial hospital admission, moderate complexity 100 $98 $328
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope 61 $75 $551
Initial hospital admission, high complexity 53 $130 $452
Upper GI endoscopy with biopsy 43 $75 $714
Removal of polyps or growths of large bowel using an endoscope with mechanical snare 32 $192 $1,032
Diagnostic exam of large bowel using a flexible endoscope 29 $132 $846
Colonoscopy with biopsy 22 $119 $900
Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth 18 $105 $557
Hospital follow-up visit, high complexity 14 $91 $299
Insertion of stomach tube using a flexible endoscope 12 $146 $707
Review by radiologist of image from tube placement into bile duct using an endoscope 12 $18 $318
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$32,726
Total received (2018-2024)
Avg $6,545/year across 5 years
Top 17% in FL for medical oncology
18
Companies
48
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$20,335 (62.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,263 (31.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,128 (6.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,903
2023
$499
2022
$372
2021
$10,086
2018
$10,866

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Shire North American Group Inc
$10,263
Ipsen Bioscience Inc.
$10,260
Takeda Pharmaceuticals U.S.A., Inc.
$10,200
Covidien LP
$387
ABBVIE INC.
$266
Endogastric Solutions, Inc
$266
E.R. Squibb & Sons, L.L.C.
$224
Ethicon Inc.
$217
Madrigal Pharmaceuticals
$140
GENZYME CORPORATION
$123
Medtronic, Inc.
$86
Boston Scientific Corporation
$80
Apollo Endosurgery US Inc
$73
Janssen Biotech, Inc.
$59
Ferring Pharmaceuticals Inc.
$26
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$22
Olympus Corporation of the Americas
$21
BOSTON SCIENTIFIC CORPORATION
$11
Top 3 companies account for 93.9% of total payments
Associated products mentioned in payments ›
BARRX · Barrx · CREON · DUPIXENT · ENTYVIO · ESOPHYX · EXALT Model D · LINX Reflux Management System · OverStitch Endoscopic Suturing System · REBYOTA · REMICADE · REZDIFFRA · SKYRIZI · SPYGLASS · VISIGLIDE · XIFAXAN · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (62%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $5,701 per 100 Medicare services performed
Looking for a medical oncology specialist in Pensacola?
Compare medical oncologists in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
2
Per 100K population
0.6
County median income
$65,715
Nearest hospital
SACRED HEART HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kumar is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 17% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kumar experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Kumar performed 178 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kumar receive payments from pharmaceutical companies?
Yes. Dr. Kumar received a total of $32,726 from 18 companies across 48 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kumar's costs compare to other medical oncologists in Pensacola?
Dr. Kumar's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kumar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Medical Oncologists in Pensacola
Browse medical oncologists in Pensacola ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Shire North American Group Inc Payments to Doctors
See all physicians who received payments from Shire North American Group Inc.
By company
Ipsen Bioscience Inc. Payments to Doctors
See all physicians who received payments from Ipsen Bioscience Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →